Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (23)

2022

  1. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

    International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392

2021

  1. Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

    Annals of Hematology, Vol. 100, Núm. 4, pp. 1023-1029

2019

  1. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

    Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966

2018

  1. Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation

    Seminars in Hematology, Vol. 55, Núm. 4, pp. 189-196

2017

  1. Role of 18F-FDG PET/CT in primary brain lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 298-303

2015

  1. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant

    Transplantation Proceedings

  2. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma

    European Journal of Haematology, Vol. 94, Núm. 1, pp. 23-30

  3. Vasculopatía oclusiva por crioglobulinemia tipo I en mieloma múltiple IgG lambda

    Revista Clinica Espanola, Vol. 215, Núm. 5, pp. e39-e42

2014

  1. Diagnóstico diferencial de las complicaciones víricas del paciente inmunodeprimido sin infección por el VIH

    Medicine (Spain), Vol. 11, Núm. 50, pp. 2982-2986

2013

  1. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

    Medical Mycology, Vol. 51, Núm. 2, pp. 150-154

  2. Lymphocytic lymphoma/chronic lymphocytic leukemia in a solid-organ donor: An unestablished risk in elderly donors

    Transplantation

2010

  1. Utilización de bisfosfonatos en pacientes con mieloma múltiple: recomendaciones del comité de expertos del Grupo Español de Mieloma del Programa Español de Tratamientos en Hematología

    Medicina Clinica, Vol. 134, Núm. 6, pp. 268-278

2007

  1. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

    Haematologica, Vol. 92, Núm. 11, pp. 1489-1494

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

  2. Medicinas alternativas y complementarias en pacientes con neoplasias linfoides

    Medicina Clinica

2003

  1. Anxiety and depression in caregivers and patients with lymphoid neoplasm [1]

    Medicina Clinica

  2. Cosmopolitan HTLV-Ia subtype among Spanish native patients

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 7, pp. 609-611

2002

  1. Identification of two atypical PML-RARα transcripts in two patients with acute promyelocytic leukemia

    Leukemia Research, Vol. 26, Núm. 5, pp. 439-442

2001

  1. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARα isoforms: A study of the PETHEMA group

    British Journal of Haematology, Vol. 114, Núm. 1, pp. 99-103

1998

  1. Déficit de hierro y pica

    Sangre, Vol. 43, Núm. 1, pp. 31-34